Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) vs Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
Side-by-side comparison of two grants.
| Attribute | Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) | Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | $500K | — |
| Deadline | Closes 2026-09-07 | Closes 2028-01-07 |
| Region | US | US |
| Sector | Health | Health |
| Funder | National Institutes of Health | National Institutes of Health |
| Who it's for | nonprofits, researchers, government | nonprofits, researchers, government |